SEARCH

SEARCH BY CITATION

The Effect of Long-term Testosterone (testosterone-undecanoate) Replacement Therapy on Prostate Specific Antigen and Prostate Volume in Hypogonadal Men

F. Sommer, U. Schwarzer, A. Christoph, M. Schubert, D. Huebler, M. Oettel, U. Engelmann, F. Jockenhoevel

Correction for The Journal of Sexual Medicine ( 2005) Suppl 1, 50–1.

The abstract was printed without the results section. The results section should read as follows:

Results. Intramuscular injections of testosterone were well tolerated. Under the influence of testosterone therapy there was a significant increase of mean PSA-value from 0.20 ± 0.29 (standard deviation, SD) ng/mL at baseline to 0.63 ± 0.39 ng/mL after 30 weeks with no significant difference between the two groups, 0.69 ± 0.33 ng/mL (54 weeks), 0.75 ± 0.37 ng/mL (90 weeks), followed by a stable level of 0.74 ± 0.36 ng/mL (114 weeks) and an insignificant decrease to 0.69 ± 0.30 after 138 weeks. After the initiation of testosterone replacement the mean prostate volume increased from 14.4 ± 4.8 (SD) mL to 18.9 ± 7.1 mL after 30 weeks, 20.4 ± 6.6 mL (54 weeks), 22.0 ± 8.8 mL (90 weeks), 23.2 ± 8.1 mL (114 weeks) and 24.9 ± 9.1 mL after 138 weeks.